Cargando…
319O The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680629/ http://dx.doi.org/10.1016/j.annonc.2020.10.313 |
| _version_ | 1783612472974901248 |
|---|---|
| author | Dettorre, G. Diamantis, N. Loizidou, A. Piccart, M. Chester, J. Jackson, A. Tovazzi, V. Fotia, V. Sita-Lumsden, A. Bower, M. Gaidano, G. Felip, E. Ottaviani, D. Sng, C. Rimassa, L. Santoro, A. Aguilar-Company, J. Seguí, E. Dolly, S. Pinato, D. |
| author_facet | Dettorre, G. Diamantis, N. Loizidou, A. Piccart, M. Chester, J. Jackson, A. Tovazzi, V. Fotia, V. Sita-Lumsden, A. Bower, M. Gaidano, G. Felip, E. Ottaviani, D. Sng, C. Rimassa, L. Santoro, A. Aguilar-Company, J. Seguí, E. Dolly, S. Pinato, D. |
| author_sort | Dettorre, G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7680629 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76806292020-11-23 319O The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection Dettorre, G. Diamantis, N. Loizidou, A. Piccart, M. Chester, J. Jackson, A. Tovazzi, V. Fotia, V. Sita-Lumsden, A. Bower, M. Gaidano, G. Felip, E. Ottaviani, D. Sng, C. Rimassa, L. Santoro, A. Aguilar-Company, J. Seguí, E. Dolly, S. Pinato, D. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2020-11 2020-11-22 /pmc/articles/PMC7680629/ http://dx.doi.org/10.1016/j.annonc.2020.10.313 Text en Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Dettorre, G. Diamantis, N. Loizidou, A. Piccart, M. Chester, J. Jackson, A. Tovazzi, V. Fotia, V. Sita-Lumsden, A. Bower, M. Gaidano, G. Felip, E. Ottaviani, D. Sng, C. Rimassa, L. Santoro, A. Aguilar-Company, J. Seguí, E. Dolly, S. Pinato, D. 319O The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection |
| title | 319O The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection |
| title_full | 319O The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection |
| title_fullStr | 319O The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection |
| title_full_unstemmed | 319O The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection |
| title_short | 319O The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection |
| title_sort | 319o the systemic pro-inflammatory response identifies cancer patients with adverse outcomes from sars-cov-2 infection |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680629/ http://dx.doi.org/10.1016/j.annonc.2020.10.313 |
| work_keys_str_mv | AT dettorreg 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT diamantisn 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT loizidoua 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT piccartm 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT chesterj 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT jacksona 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT tovazziv 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT fotiav 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT sitalumsdena 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT bowerm 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT gaidanog 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT felipe 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT ottavianid 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT sngc 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT rimassal 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT santoroa 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT aguilarcompanyj 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT seguie 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT dollys 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection AT pinatod 319othesystemicproinflammatoryresponseidentifiescancerpatientswithadverseoutcomesfromsarscov2infection |